Spec play KRMD KORU Medical Systems, Inc.

KRMD as a spec play seems interesting and might be worthy of being placed on a watch list.

Per Zacks Investment research,

quote:

---

KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J.

---

Closed today at $3.06. Per TipRanks, it's covered by 5 analysts, high target price of $8 and low target of $5, with a consensus target price of $6.30. FWIW, Zacks rates it a 2, i.e. a Buy.

Here's a link to KRMD's Second Quarter 2026 Results and Updates Full Year 2026 Guidance: LINK

And here's a link to a transcript of the 2026 Second Quarter conference call: LINK

ETA: FWIW, on September 8, 2026, the Chief Commercial Officer bought 32,000 shares @ a price of $3.16 per share. LINK